CClinicalTrials.gg
CompletedNCT06122155Updated Nov 14, 2023

Effects of Posterior Parietal Cortex and Cerebellum Anodal tDCS on Ankle Tracking Visuomotor Adaptation

An interventional study of Transcranial direct current stimulation (Anodal) and Transcranial direct current stimulation (Sham) in Transcranial Direct Current Stimulation, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-14.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Nov 2022, registered Oct 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 29 Years
Sex
All
01

Study summary

Motor adaptation is guided by state estimation, a dynamic prediction of the interaction consequences between body and environment in the sensorimotor system. Previous studies have shown that the posterior parietal cortex (PPC) and cerebellum are potential candidates for state estimators. However, neither direct evidence linking neural substrates of state estimation and motor adaptation nor the differences in state estimation in these two brain areas was presented. A comparison of neuromodulation effects over PPC and cerebellum in motor adaptation tasks could provide direct evidence to solve the knowledge gap.

Objective: This study aims to provide direct evidence to link state estimation and motor adaptation, and the neuromodulation effects of PPC and cerebellum in motor adaptation by using anodal transcranial direct current stimulation.

Read the detailed description

This was a single-blind, sham-controlled study. All participants were randomized to the PPC, cerebellum, and sham stimulation group. The ankle tracking system was used to record the ankle tracking visuomotor task during the motor learning phase, motor adaptation phase, and motor re-adaptation phase. Normalized root-mean squared error (RMSE) and RMSE reduction rate were measured as the performance outcome. A 20-minute atDCS at 2 mA anodal tDCS was given during the motor adaptation phase. The immediate effect and after effect of tDCS were seen in the motor adaptation phase and motor re-adaptation phase, respectively.

02

Conditions studied

  • Transcranial Direct Current Stimulation

Keywords

  • Transcranial Direct Current Stimulation
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • age between 20\~29 years old
  • normal ankle range of motion and muscle strength
  • intact cognitive function (Mini-mental State Examination (MMSE) >27)
  • corrected vision > 0.9.

Exclusion criteria

Exclusion Criteria:

  • any neurologic or psychiatric disease history
  • musculoskeletal disease that interferes lower extremities movement
  • severe cardiopulmonary or systematic disease (e.g. unstable angina, severe arrhythmia, heart failure, hypertrophic cardiomyopathy, aortic stenosis, pulmonary embolism, kidney failure)
  • paresthesia
  • seizure history
  • brain surgery, meningitis, encephalitis history
  • drainage tube on the head
  • metal or other insertion in the brain
  • insertion of electric medical device (e.g. pacemaker, cochlear implant)
  • pregnancy
  • taking central nervous system medication (e.g. antidepressants, anxiolytic)
  • alcoholic addiction or drug abuse
  • open wound, allergy, rash, or other illness that would affect the placement of tDCS
  • headache, disgusting, vomit, or any other severe side effect to the tDCS
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Posterior parietal cortex (PPC)

    In the motor adaptation phase, a 20-minute, 2 mA anodal tDCS was delivered through two 5cm x 7cm electrodes using the DC-STIMULATOR MR (neuroConn, Germany). The electrical current gradually ramps up and down in 20 seconds. In the PPC group, the anodal electrode was placed over the P3 or P4 areas on the skull, covering the PPC area on the opposite side of the testing foot (according to the international 10-20 EEG system), and the reference electrode was placed over the supraorbital region on the same side of the testing foot.

    Device: Transcranial direct current stimulation (Anodal)

  • Experimental
    Cerebellum

    In the motor adaptation phase, a 20-minute, 2 mA anodal tDCS was delivered through two 5cm x 7cm electrodes using the DC-STIMULATOR MR (neuroConn, Germany). The electrical current gradually ramps up and down in 20 seconds. In the cerebellum group, the anodal electrode was placed 1\~2 cm under and 3\~4 cm lateral to the inion on the same side of the testing foot, with the reference electrode placed on the buccinator on the same side of the testing foot.

    Device: Transcranial direct current stimulation (Anodal)

  • Sham comparator
    Sham

    In the motor adaptation phase, a 20-minute, 0 mA anodal tDCS was delivered through two 5cm x 7cm electrodes using the DC-STIMULATOR MR (neuroConn, Germany) for the sham group. Participants were informed that they might experience itchiness, burning, or mild discomfort during the tDCS period regardless of which group they were assigned to, so they would not use their sensation as a basis for determining whether they received actual stimulation or not.

    Device: Transcranial direct current stimulation (Sham)

Interventions

  • DeviceTranscranial direct current stimulation (Anodal)

    20-minutes, 2 mA anodal tDCS delivering through two 5 cm x 7 cm electrodes

  • DeviceTranscranial direct current stimulation (Sham)

    20-minutes, 0 mA anodal tDCS delivering through two 5 cm x 7 cm electrodes

06

What researchers measure

Primary outcomes

  1. Block root-mean squared error (RMSE)

    RMSE is the error between target trajectory and subject cursor trajectory. Every 5 trials of RMSE were averaged into one block.

    Time frame: 2 hours during the time of assessment of the participant

  2. RMSE reduction rate

    ΔRMSEi-(i+1) = (RMSEi - RMSEi+1) / RMSEi x 100%

    Time frame: 2 hours during the time of assessment of the participant

07

Study locations

1 site
  • National Taiwan University
    Taipei, 100, Taiwan
08

References and documents

Individual participant data

Plan to share: No — undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06122155
Lead sponsor
National Taiwan University Hospital
Collaborators
National Science and Technology Council
Responsible party
Sponsor
First posted
Nov 8, 2023
Start date
Nov 26, 2022
Primary completion
Jun 19, 2023
Completion
Jun 19, 2023
Last update
Nov 14, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion